S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495].

WI, N., S, R., F, H., JS, T., & PW, H. (2004). S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskeletal Disorders, 5. Retrieved from Available in fulltext at http://nhs5195535.resolver.library.nhs.uk/linker?linkScheme=bmc&linktype=best&genre=article&volume=5&spage=6&issn=1471-2474&date=2004-02&aulast=Najm&auinit=WI&title=BMC+Musculoskeletal+Disorders&atitle=S-adenosyl+methionine+%28SAMe%29+versus+celecoxib+for+the+treatment+of+osteoarthritis+symptoms%3A+a+double-blind+cross-over+trial.+%5BISRCTN36233495%5D.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fwww.biomedcentral.com%2